CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 20,054 shares (to pay taxes)
- 4 Open-market sale President sold 22,394 shares at $4.55 ($101,893)
- 4 Open-market sale SVP, Treasurer & CAO sold 21,570 shares at $4.55 ($98,144)
- 4 Grant or award Director acquired 31,780 shares (grant or award)
- 4 Open-market sale General Counsel and Secretary sold 16,853 shares at $4.55 ($76,681)
- 4 Shares withheld for taxes Director gave up 40,107 shares (to pay taxes)
- 4 Open-market sale EVP, GM Cell Therapy sold 24,890 shares at $4.55 ($113,250)
- 4 Open-market sale EVP, GM Gene Therapy sold 27,923 shares at $4.55 ($127,050)
- 4 Grant or award Director acquired 31,780 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 110,694 shares at $4.88 ($540,187)
- 4 Open-market sale SVP, Treasurer & CAO sold 11,667 shares at $5.25 ($61,252)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 424B7 Offering Prospectus
Page 21 of 65 · 1,296 filings